R. Hustinx

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)

Guy Jérusalem, Yves Béguin, Fadi Najjar et al. · Annals of Oncology · 2001 · 268 citations

Medicine, Nuclear Medicine, Oncology +12

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

Guy Jérusalem, Yves Béguin, Marie France Fassotte et al. · Annals of Oncology · 2002 · 215 citations

Medicine, Oncology, Radiology +15

Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67

Tarik Belhocine, J.B. Foidart, P. Rigo et al. · Nuclear Medicine Communications · 2002 · 129 citations

Medicine, Nuclear Medicine, Oncology +17

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)

Anne‐Ségolène Cottereau, Stéphanie Becker, Florence Broussais et al. · Annals of Oncology · 2016 · 113 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1.

Sydney M. Evans, Alexander V. Kachur, Chyng‐Yann Shiue et al. · PubMed · 2000 · 93 citations

Medicine, Nuclear Medicine, Oncology +17